Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Panel To Assess Larger Production Scale Of Genzyme’s Myozyme For Pompe’s Disease

This article was originally published in The Pink Sheet Daily

Executive Summary

Advisory committee recommendations could carry influence in the follow-on biologics debate.

You may also be interested in...



FDA calls one Myozyme different from another

FDA tells Genzyme that Myozyme for Pompe's disease made at the firm's 160-liter bioreactor scale is a different product from the same drug made at the 2,000-liter scale, which means approval of the 2,000-liter drug will be delayed - a move that could heighten concerns about the agency's powers regarding biosimilars. Regulators say the carbohydrate structure distinguishes the two Myozymes. Genzyme will put together a new BLA for the 2,000-liter version. The Biotechnology Industry Organization declines comment about FDA leeway and pending biosimilars legislation, saying the questions relate to an individual BIO member's news

IFRA Hosts Capitol Hill Scent Experience In Timeout From Policy Concerns

The International Fragrance Association North America took a break from its higher-stakes advocacy work Nov. 1 to give lawmakers and congressional staffers a "scent experience." Perfumers from six of the group's biggest members were on hand with "Scents of Home," joined by Monell Center researchers to educate attendees on the mechanics of scent and the important role it plays in people's lives.

NSF's Cosmetics Verification Program Fizzles, While EWG's Could See Second Boom

NSF International has put its cosmetic product verification program on ice due to lack of interest since its launch in April 2017. Meanwhile, more than 1,000 products from 75+ brands have earned the "EWG Verified" mark, and the NGO says interest is higher than ever following Walmart's announcement in September that it will begin pushing vendors to pursue the verification.

Topics

UsernamePublicRestriction

Register

OM017175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel